SecBot SecBot
144 ·Filed Nov 9, 2026

BIO

BIO-RAD LABORATORIES, INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed7d 11h ago SEC0001950047-26-010836
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

This is a small, routine insider sale by an officer following restricted stock vesting. No material impact on the stock is expected. Monitor for any subsequent Form 4 filings to confirm execution.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$386.48
T+0 close · Nov 9, 2026 · via day close
Latest settled
−0.12%
T+1 · $386.00 · next T+5 in 4h
Vs SPY
−1.44%
α at T+1
Latest observation
−4.75%
T+4 · FF3 residual α
  1. T+0 · Nov 10 $386.48entry
  2. T+1 · 6d ago −0.12%α −1.44% · $386.00
  3. T+4 · todayOpen
  4. T+5 · in 4h Pending
  5. T+20 · in 22d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

James Barry, an officer of Bio-Rad Laboratories, filed a Form 144 notice of intent to sell 1,400 shares of common stock with an approximate market value of $539,877. The shares were acquired through restricted stock vestings in September 2026. The sale is small relative to the company's $9.9B market cap and represents a routine insider sale.

Key Facts

  • James Barry, an officer of Bio-Rad Laboratories, filed a Form 144 on November 9, 2026.
  • The proposed sale is for 1,400 shares of common stock.
  • The approximate market value of the proposed sale is $539,877.
  • The shares were acquired through restricted stock vestings on September 1, 5, and 6, 2026.
  • The sale is to be executed through Morgan Stanley Smith Barney LLC.
  • The proposed sale date is November 9, 2026.

Financial Impact

Proposed sale of 1,400 shares worth approximately $539,877, representing about 0.005% of the company's $9.9B market cap.

dilution

Risk Factors

  • The sale may not be executed; Form 144 is only a notice of intent.
  • No other insider selling patterns or context provided to suggest broader insider sentiment.

Market Snapshot

Exchange
NYSE
Sector
Laboratory Analytical Instruments
Analyst Consensus
50% bullish (10 analysts)

Investment Themes

Industrials & Manufacturing

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-010836
Document: 0001950047-26-010836-index.html0001950047-26-010836
Document: 0001950047-26-010836.txt0001950047-26-010836

US Market Status

Market Closed · Opens in 6h 4m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 9, 2026